As part of a revised standard published this week, the American Academy of Pediatrics says boys should be routinely vaccinated against the human papillomavirus (HPV), a common virus that is spread through sexual contact. Although there are dozens of types of HPV, vaccines can protect both male and females against some […]
Filed under: Cervical Cancer on February 3rd, 2012 | No Comments »
The CDC’s Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule published February 1 in Annals of Internal Medicine, the flagship journal of […]
Filed under: Cervical Cancer on February 3rd, 2012 | No Comments »
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM…
More: continued here
Filed under: Cervical Cancer on January 28th, 2012 | No Comments »
Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes or multiple sclerosis after vaccination in young women, according to a new study in the Journal of Internal Medicine…
More: continued here
Filed under: Cervical Cancer on January 28th, 2012 | No Comments »
A study published January 23 in the Journal of the National Cancer Institute , has found that self-HPV (human papillomavirus) testing, in low-resource settings, may be a more effective way to screen for cervical cancer than liquid-based cytology (LBC) and visual inspection with acetic acid (VIA). Cervical cancer is one of the most prevalent […]
Filed under: Cervical Cancer on January 26th, 2012 | No Comments »
Precursors of cervical cancer can be detected and treated earlier / Risk of over-treatment Studies currently available provide indications and a “hint” that precursors of cervical cancer can be detected and treated earlier, and consequently tumours occur less often, in women who underwent testing for human papillomavirus (HPV)…
More: continued here
Filed under: Cervical Cancer on January 26th, 2012 | No Comments »
Human papillomavirus (HPV) testing of self-collected specimens may be a more effective way to screen for cervical cancer in low-resource settings compared to visual inspection with acetic acid (VIA) and liquid-based cytology (LBC), according to a study published in the Journal of the National Cancer Institute…
More: continued here
Filed under: Cervical Cancer on January 24th, 2012 | No Comments »
According to a study published in the current issue of the journal Cancer Prevention Research, aspirin should be assessed for its ability to prevent cervical cancer developing in women infected with HIV. Aspirin has the potential to provide considerable benefit for women in Africa, the Caribbean and Latin America, regions where death rates from […]
Filed under: Cervical Cancer on January 21st, 2012 | No Comments »
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women…
More: continued here
Filed under: Cervical Cancer on January 21st, 2012 | No Comments »
According to a study in PLoS Medicine, the most effective strategy to protect against human papillomavirus (HPV) is single-sex vaccination. They also found that it was preferable to vaccinate females instead of men, given that females are the sex with the highest prevaccine prevalence of HPV infection…
More: continued here
Filed under: Cervical Cancer on January 5th, 2012 | No Comments »